Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as...
22 KB (1,841 words) - 22:50, 30 April 2024
desensitization and therapy, dupilumab (Dupixent) was show to be the most effective across six different patient-important outcomes. Dupilumab and omalizumab have...
50 KB (5,530 words) - 02:09, 6 June 2024
are still limitations to the use of anti-IL-13 monoclonal antibodies. Dupilumab is a newer drug that targets the shared receptor of IL-4 and IL-13, IL4Rα...
20 KB (2,271 words) - 04:25, 12 May 2024
have showed that abrocitinib improved the EASI scores in comparison with dupilumab, even in the second week of treatment. A faster onset of Investigator's...
25 KB (2,608 words) - 03:22, 25 April 2024
inhibits PDGF-BB in hypereosinophilic leukemia Monoclonal antibodies such as dupilumab and lebrikizumab target IL-13 and its receptor, which reduces eosinophilic...
27 KB (2,943 words) - 06:43, 6 April 2024
nodularis is very hard to treat, but current therapies include steroids, dupilumab, vitamins, cryosurgery, thalidomide and UVB light[citation needed]. In...
14 KB (1,445 words) - 08:44, 9 May 2024
azathioprine, and methotrexate. Dupilumab is a new medication that improves eczema lesions, especially moderate to severe eczema. Dupilumab, a monoclonal antibody...
69 KB (7,002 words) - 01:03, 19 May 2024
July 2015, It is reported to cost $4,500 to $8,000 per year. Dupixent (dupilumab injection) is for the treatment of adolescent and adult patients' atopic...
26 KB (2,237 words) - 08:36, 9 May 2024
for stable angina, marketed by Gilead Sciences. – Dermatology Dupixent (Dupilumab), for eczema, marketed by Regeneron. Dynabac (Dirithromycin), for acute...
90 KB (8,728 words) - 23:51, 22 May 2024
capsule". dailymed.nlm.nih.gov. Retrieved 2021-07-01. "DailyMed - DUPIXENT- dupilumab injection, solution". dailymed.nlm.nih.gov. Retrieved 2021-07-01. "DailyMed...
11 KB (842 words) - 13:15, 12 February 2024
unknown origin. However, there are clinical trials currently underway with dupilumab which is thought to alleviate itch by acting on the IL-4 receptor on sensory...
34 KB (3,718 words) - 10:19, 5 June 2024
cases may need systemic medicines such as cyclosporin, methotrexate, dupilumab or baricitinib. Other names of the condition include "infantile eczema"...
81 KB (8,396 words) - 02:21, 5 June 2024
year are unknown. Monoclonal antibody injections such as mepolizumab, dupilumab, or omalizumab may be useful in those with poorly controlled atopic asthma...
166 KB (17,940 words) - 01:50, 21 May 2024
D11AH02 Pimecrolimus D11AH03 Cromoglicic acid D11AH04 Alitretinoin D11AH05 Dupilumab D11AH06 Crisaborole D11AH07 Tralokinumab D11AH08 Abrocitinib D11AH09 Ruxolitinib...
2 KB (293 words) - 04:48, 18 December 2023
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
199 KB (19,821 words) - 00:36, 2 June 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
50 KB (5,401 words) - 02:51, 14 May 2024
signaling on sensory neurons, which critically informed new therapies like dupilumab. Kim's group also was the first lab to identify JAK1 signaling in sensory...
10 KB (899 words) - 13:49, 24 April 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
34 KB (3,419 words) - 05:34, 8 June 2024
in symptoms. In May 2022, U.S. Food and Drug Administration approved dupilumab (Dupixent) to treat eosinophilic esophagitis (EoE) in adults and pediatric...
32 KB (3,690 words) - 15:37, 1 February 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
48 KB (4,530 words) - 17:50, 27 April 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
187 KB (18,318 words) - 01:32, 24 May 2024
Binetrakin Interleukin 4 Interleukin 13 Antagonists: Pitrakinra Antibodies: Dupilumab Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies:...
14 KB (1,578 words) - 14:00, 26 February 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
23 KB (2,330 words) - 16:48, 11 May 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
79 KB (7,752 words) - 14:05, 1 June 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
3 KB (215 words) - 04:24, 22 March 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
74 KB (7,428 words) - 17:44, 10 April 2024
IL-13-specific blockers: Lebrikizumab Tralokinumab Dual IL-4 and IL-13 blockers: Dupilumab IgE-blockers: Ligelizumab Omalizumab Allen, Judith E.; Sutherland, Tara...
5 KB (560 words) - 21:43, 1 April 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
91 KB (9,169 words) - 15:38, 18 May 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
34 KB (3,039 words) - 08:54, 4 June 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
15 KB (1,192 words) - 19:40, 23 March 2024